Position in JNJ
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$18,285
+$2,397 QoQ
Shares Held
72
+10.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4,651
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WestEnd Advisors, LLC holds $138,199 across 9 Drug Manufacturers - General names. JNJ ranks #3 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
159 | $40,010 | |
| 2 | LLY |
ELI LILLY & Co
|
24 | $28,786 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
72 | $18,285 | |
| 4 | AMGN |
Amgen Inc
|
48 | $17,381 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
111 | $14,023 | |
| 6 | MRK |
Merck & Co., Inc.
|
73 | $9,380 | |
| 7 | PFE |
Pfizer Inc
|
169 | $4,069 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
60 | $3,457 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,285 | 72 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $15,888 | 65 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $13,451 | 65 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $13,350 | 72 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $15,886 | 104 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $15,257 | 92 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $5,784 | 40 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $5,510 | 34 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $6,723 | 46 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $32,859,068 | 207,719 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $32,533,267 | 207,562 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $33,379,561 | 214,315 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $34,663,198 | 209,420 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $33,075,605 | 213,391 | Principal | Other | 2023-04-28 | |
| 2022-12-31 | $34,400,821 | 194,740 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $33,623,735 | 205,826 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $36,709,955 | 206,805 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $44,860,989 | 253,123 | Principal | Other | 2022-04-26 | |
| 2021-12-31 | $46,516,156 | 271,913 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $43,302,833 | 268,129 | Principal | Sole | 2021-10-26 | |
| 2021-06-30 | $44,026,600 | 267,249 | Principal | Sole | 2021-07-15 | |
| 2021-03-31 | $40,385,232 | 245,727 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $36,605,801 | 232,595 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $35,580,384 | 238,987 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $32,815,166 | 233,344 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $28,752,875 | 219,270 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||